[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353931-105":59,"doc-detail-353931-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ultrasound-assisted-synthesis-and-biological-profiling-of-135-triazine-derivatives-with-antiproliferative-activity-in-triple-negative-breast-cancer-research-findings","Ultrasound-Assisted Synthesis and Biological Profiling of 1,3,5-Triazine Derivatives with Antiproliferative Activity in Triple-Negative Breast Cancer - Research Findings","","Triple-negative breast cancer (TNBC) remains one of the most aggressive breast cancer subtypes, with limited therapeutic options that require novel strategies. This study develops a library of seventeen 1,3,5-triazine derivatives designed to target TNBC via an activity-based approach. Ultrasound-assisted synthesis enables efficient, environmentally friendly preparation. The compounds are tested in vitro on TNBC lines MDA-MB-468, MDA-MB-231, and Hs578T, and on MCF10A non-tumorigenic epithelial cells. Compounds 9 and 17 show the strongest antiproliferative activity with acceptable selectivity, followed by in vivo zebrafish evaluation for toxicity and cardiotoxicity, plus ADME predictions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ultrasound-assisted-synthesis-and-biological-profiling-of-135-triazine-derivatives-with-antiproliferative-activity-in-triple-negative-breast-cancer-research-findings/353931/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ultrasound-assisted-synthesis-and-biological-profiling-of-135-triazine-derivatives-with-antiproliferative-activity-in-triple-negative-breast-cancer-research-findings/353931.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study?","Question",{"text":112,"@type":113},"To synthesize and biologically profile a library of 1,3,5-triazine derivatives with potential antiproliferative activity against triple-negative breast cancer (TNBC).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the 1,3,5-triazine derivatives synthesized?",{"text":117,"@type":113},"The compounds were synthesized using an ultrasound-assisted protocol, described as efficient and environmentally friendly.",{"name":119,"@type":110,"acceptedAnswer":120},"Which compounds showed the strongest results and how were they evaluated further?",{"text":121,"@type":113},"Compounds 9 and 17 showed the most promising antiproliferative activity in TNBC cell lines while maintaining acceptable selectivity. They were further assessed in vivo using a Danio rerio model for toxicity and cardiotoxicity, and ADME parameters were predicted using biomimetic chromatography.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353931,1790786958,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","Article  \nUltrasound-Assisted Synthesis and Biological Profiling of 1,3,5-Triazine Derivatives with Antiproliferative Activity in Triple-Negative Breast Cancer  \nNatalia Bosak 1, Anna Karolina Drabczyk 1, Jolanta Ja´skowska 1, Martyna Stachowicz-Suhs 2,3, Beata Filip-Psurska 4, Anna Boguszewska-Czubara 5, Katarzyna Ewa Greber 6, Krzesimir Ciura 6 and Damian Kułaga 1, *  \nAcademic Editor: Alok Bhushan  \nReceived: 13 February 2026  \nRevised: 8 March 2026  \nAccepted: 13 March 2026  \nPublished: 17 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Organic Chemistry and Technology, Faculty of Chemical Engineering and Technology, Cracow University of Technology, 24 Warszawska Street, 31-155 Cracow, Poland; [natalia.bosak54@student.pk.edu.pl](natalia.bosak54@student.pk.edu.pl) (N.B.); [anna.drabczyk@pk.edu.pl](anna.drabczyk@pk.edu.pl) (A.K.D.); [jolanta.jaskowska@pk.edu.pl](jolanta.jaskowska@pk.edu.pl) (J.J.)  \n2 Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 Weigla Street, 53-114 Wroclaw, Poland  \n3 Innate Immunity Research Group, Life Sciences and Biotechnology Center, Łukasiewicz Research Network-PORT Polish Center for Technology Development, 147 Stabłowicka Street, 54-066 Wrocław, Poland; [martyna.stachowicz-suhs@port.lukasiewicz.gov.pl](martyna.stachowicz-suhs@port.lukasiewicz.gov.pl)  \n4 Laboratory of Experimental Anticancer Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 Weigla Street, 53-114 Wroclaw, Poland; [beata.filip-psurska@hirszfeld.pl](beata.filip-psurska@hirszfeld.pl)  \n5 Department of Medical Chemistry, Medical University of Lublin, 4a Chod´zki Street, 20-093 Lublin, Poland; [anna.boguszewska-czubara@umlub.pl](anna.boguszewska-czubara@umlub.pl)  \n6 Department of Physical Chemistry, Faculty of Pharmacy, Medical University of Gdansk, 107 General Jozef Haller Avenue, 80-416 Gdansk, Poland; [katarzyna.greber@gumed.edu.pl](katarzyna.greber@gumed.edu.pl) (K.E.G.); [krzesimir.ciura@gumed.edu.pl](krzesimir.ciura@gumed.edu.pl) (K.C.)  \n* Correspondence: [damian.kulaga@pk.edu.pl](damian.kulaga@pk.edu.pl)  \nAbstract  \nTriple-negative breast cancer (TNBC) remains one of the most aggressive breast cancer subtypes and is associated with limited therapeutic options, underscoring the urgent need for novel treatment strategies. In this study, a library of seventeen 1,3,5-triazine derivatives potentially targeting TNBC was developed using an activity-based approach. Compounds were synthesized via an ultrasound-assisted protocol, providing an efficient and environmentally friendly methodology. The synthesized library was evaluated in vitro against the human TNBC cell lines MDA-MB-468, MDA-MB-231, and Hs578T, as well asthe non-tumorigenic epithelial cell line MCF10A. Compounds 9 and 17 exhibited the most promising antiproliferative activity against TNBC cell lines (MDA-MB-468: IC50 = 36.62 µM for 9 and 38.29 µM for 17; MDA-MB-231: IC50 = 37.32 µM for 9 and 32.86 µM for 17; Hs578T: IC50 = 57.26 µM for 9 and 34.87 µM for 17), while maintaining acceptable selectivity toward non-cancerous cells. The lead compounds were further assessed in vivo using a Danio rerio model to evaluate general toxicity and cardiotoxicity. In addition, ADME parameters were predicted for all compounds using biomimetic chromatography. Overall, compounds 9 and 17 emerged as promising small-molecule candidates for TNBC treatment, requiring further toxicological evaluation in more human-relevant in vivo models.  \nKeywords: triple-negative breast cancer; 1,3,5-triazine; sonochemistry; ultrasound-assisted synthesis; green chemistry  \n1. Introduction  \nTriple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer, accounting for ","cbCaihd2UvJX5GG8","https://ap.wps.com/l/cbCaihd2UvJX5GG8","pdf",969758,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To synthesize and biologically profile a library of 1,3,5-triazine derivatives with potential antiproliferative activity against triple-negative breast cancer (TNBC).\"},{\"question\":\"How were the 1,3,5-triazine derivatives synthesized?\",\"answer\":\"The compounds were synthesized using an ultrasound-assisted protocol, described as efficient and environmentally friendly.\"},{\"question\":\"Which compounds showed the strongest results and how were they evaluated further?\",\"answer\":\"Compounds 9 and 17 showed the most promising antiproliferative activity in TNBC cell lines while maintaining acceptable selectivity. They were further assessed in vivo using a Danio rerio model for toxicity and cardiotoxicity, and ADME parameters were predicted using biomimetic chromatography.\"}]","Ultrasound-Assisted Synthesis and Biological Profiling of 1,3,5-Triazine Derivatives with Antiproliferative Activity in Triple-Negative Breast Cancer - Research Findings | PDF",1790108002,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c469a6a1601d78057785c200be1c5bac.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e025219ae4befe5616fb9247af6a161.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0507bba48cae6a2f9d257e63b20c6af0.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc04fe8454ce06f8c8a99f540b1e9cbe.webp",980,1385]